Neurogene Inc. (NGNE) — Financial statements
Income statement, balance sheet, and cash flow for Neurogene Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00↓100.0% | 0.93 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 3↓1.7% | 3↓0.5% | 3↑2.1% | 3↓92.4% | 42 | |
| Gross Profit | -3↓37.5% | -2↑28.8% | -3↓2.1% | -3↑92.4% | -42 | |
| Operating Expenses | ||||||
| R&D Expenses | 75↑23.1% | 61↑37.2% | 44↓6.5% | 48↑12.4% | 42 | |
| General & Administrative Expenses | 0.00↓100.0% | 23↑102.1% | 11↑24.2% | 9↑9.0% | 8 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 25↑11.1% | 23↑102.1% | 11↑24.2% | 9↑9.0% | 8 | |
| Other Expenses | 0.00↑100.0% | -3↑0.5% | -3↓2.1% | -3↑92.4% | -42 | |
| Operating Expenses | 100↑24.6% | 80↑53.4% | 52↓1.9% | 53↑544.8% | 8 | |
| Total Costs & Expenses | 103↑23.6% | 84↑50.3% | 56↓1.7% | 57↑11.8% | 51 | |
| Operating Results | ||||||
| Operating Income | -103↓24.9% | -83↓48.6% | -56↑1.7% | -57↓11.8% | -51 | |
| Depreciation & Amortization | 0.00↓100.0% | 3↓1.5% | 3↑3.2% | 3↑237.5% | 0.95 | |
| EBITDA | -103↓43.7% | -72↓37.5% | -52↓0.6% | -52↓4.8% | -50 | |
| EBIT | -103↓37.4% | -75↓35.2% | -56↓0.7% | -55↓9.2% | -51 | |
| Interest & Other Income | ||||||
| Net Interest Income | 12↑36.5% | 8↑187.7% | 3↑120.1% | 1↑6926.3% | 0.02 | |
| Interest Income | 12↑36.4% | 8↑186.9% | 3↑120.7% | 1↑6936.8% | 0.02 | |
| Interest Expense | 0.01↓58.3% | 0.01↑0.0% | 0.01↑500.0% | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -7 | 0.00↑100.0% | -1 | 0.00 | |
| Other Income / Expenses | 13↑72.3% | 7↓61.3% | 19↑1350.8% | 1↑7711.8% | 0.02 | |
| Income Before Tax | -90↓20.2% | -75↓106.9% | -36↑34.2% | -55↓9.2% | -51 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -90↓20.2% | -75↓106.9% | -36↑34.2% | -55↓9.2% | -51 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -90↓20.2% | -75↓106.9% | -36↑34.2% | -55↓9.2% | -51 | |
| Bottom-Line Net Income | -90↓20.2% | -75↓106.9% | -36↑34.2% | -55↓9.2% | -51 | |
| EPS (Basic) | -4.24↑0.9% | -4.28↓51.2% | -2.83↑34.2% | -4.30↓367.4% | -0.92 | |
| EPS (Diluted) | -4.24↑0.9% | -4.28↓51.2% | -2.83↑34.2% | -4.30↓367.4% | -0.92 | |
| Weighted Average Shares | 21↑20.5% | 18↑37.0% | 13↑0.0% | 13↓76.7% | 55 | |
| Weighted Average Diluted Shares | 21↑20.5% | 18↑37.0% | 13↑0.0% | 13↓76.7% | 55 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.